Journal article
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Abstract
The efficacy and safety of dabigatran for treatment of venous thromboembolism (VTE) were demonstrated in two trials. It is unclear if the results pertain to patients with cancer and VTE. Data from two randomised trials comparing dabigatran and warfarin for acute VTE were pooled. Primary efficacy outcome was symptomatic recurrent VTE and related death from randomisation to the end of the treatment period. Safety outcomes were major, major and …
Authors
Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
Journal
Thrombosis and Haemostasis, Vol. 114, No. 01, pp. 150–157
Publisher
Thieme
Publication Date
2015
DOI
10.1160/th14-11-0977
ISSN
0340-6245